Statera Biopharma, Inc.
STAB
$0.0001
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -94.64% | -94.80% | 117.64% | 233.27% | 2,852.20% |
| Total Receivables | 150.62% | -- | -- | 5.92% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -96.37% | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -75.45% | 102.78% | -32.41% | 33,720.00% | 207.98% |
| Total Current Assets | -90.83% | -44.97% | 124.63% | 348.90% | 1,920.92% |
|
|
|||||
| Total Current Assets | -90.83% | -44.97% | 124.63% | 348.90% | 1,920.92% |
| Net Property, Plant & Equipment | 6.35% | 24,800.00% | 1,153.58% | 963.08% | 14,440.91% |
| Long-term Investments | -87.96% | -- | -- | -- | -- |
| Goodwill | -87.96% | -- | -- | -- | -- |
| Total Other Intangibles | -21.29% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -87.00% | -2.07% | 1,701.29% | 1,944.39% | 14,615.72% |
|
|
|||||
| Total Accounts Payable | 155.01% | 13,240.99% | 96.84% | 249.37% | 34.35% |
| Total Accrued Expenses | 251.70% | 1,402.08% | -- | 12.75% | -- |
| Short-term Debt | 107.46% | -- | 209.98% | 140.51% | 62.09% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 63.19% | -- | 1,011.32% | 727.92% | -- |
| Total Finance Division Other Current Liabilities | -44.40% | -- | -- | -- | -- |
| Total Other Current Liabilities | -44.40% | -- | -- | -- | -- |
| Total Current Liabilities | 118.22% | 6,443.71% | 181.20% | 143.36% | 138.26% |
|
|
|||||
| Total Current Liabilities | 118.22% | 6,443.71% | 181.20% | 143.36% | 138.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 107.46% | -- | 209.98% | 140.51% | 62.09% |
| Capital Leases | -6.96% | -- | 1,305.32% | 1,045.03% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.88% | 6,707.62% | 194.06% | 383.38% | 457.60% |
|
|
|||||
| Common Stock & APIC | 5.86% | 1,460.33% | 377.28% | 430.63% | 538.64% |
| Retained Earnings | -175.71% | -- | -316.91% | -366.38% | -123.31% |
| Treasury Stock & Other | 2,785.00% | -- | -- | -- | -- |
| Total Common Equity | -113.82% | -181.55% | 46.89% | 57.11% | 2,151.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -113.82% | -181.55% | 46.89% | 57.11% | 2,151.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 1.11% | -98.64% | -- | -- | -- |
| Total Equity | -113.70% | -151.16% | 47.88% | 58.78% | 2,155.54% |
|
|
|||||